Location:
Berg Family Foundation Seminar Room, Level 6, Wallace Wurth Building, Kensington Campus
The Kirby Institute invites you to our special presentation
On Demand PrEP: only for Europe?
Professor Jean-michel Molina
University of Paris 7; Department of Infectious Diseases at the Saint-Louis Hospital; and ANRS (French Agency for Research on AIDS and Viral Hepatitis)
Jean-michel Molina is Professor of Infectious Diseases at the University of Paris Diderot - Paris 7, and Head of the Infectious Diseases Department at the Saint-Louis Hospital in Paris. Professor Molina’s primary clinical research interest lies in the area of HIV infection, initially the treatment of opportunistic infections, then the treatment of HIV-infection. He has been involved in a number of studies assessing new drugs or new strategies for the treatment of HIV infection. A cohort of more than 3,500 patients with HIV-infection is followed in his department and is involved in this clinical research. He is also a member of the INSERM U941 team involved in HIV basic research the Saint-Louis hospital.
The presentation will be followed by a panel featuring
- Dr Kerry Chant Chief Medical Officer at NSW Health
- Dr Robert Finlayson Director of Taylor Square Private Clinic
- Professor Jean-michel Molina University of Paris 7, Saint-Louis Hospital and ANRS
- Ms Karen Price Deputy CEO at ACON.
Moderated by Professor Andrew Grulich Kirby Institute
Welcome by Associate Professor Garrett Prestage Kirby Institute
Program
5.00pm: Brett Tindal Memorial Lecture – Professor Jean-michel Molina
5:45pm: Panel discussion on PrEP
6:30pm: Cocktail reception
RSVPs essential. Please RSVP to events@kirby.unsw.edu.au by COB Monday 20 November.
The Brett Tindall Memorial Lecture is an annual lecture awarded by the Kirby Institute to a world leader in infectious disease research.
It is awarded in memory of Dr Brett Tindall, who was one of the Kirby Institute’s first researchers in the 1980s and died of AIDS in 1994. Brett's research focussed on the process of seroconversion and the body's responses to the entry of HIV.